Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/09/2859974/0/en/Molecular-Templates-Presents-Interim-Data-from-MT-6402-Phase-I-Study-in-Patients-with-PD-L1-Solid-Tumors-at-the-2024-American-Association-for-Cancer-Research-AACR-Annual-Meeting-Mo.html
https://www.globenewswire.com/news-release/2024/03/29/2854722/0/en/Molecular-Templates-Inc-Reports-Fourth-Quarter-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/28/2853973/0/en/Molecular-Templates-Announces-9-5-Million-Private-Placement-Offering-and-Agreement-to-Amend-Second-Tranche-of-July-2023-Purchase-Agreement.html
https://www.globenewswire.com//news-release/2024/03/04/2839568/0/en/Molecular-Templates-Inc-Provides-Interim-Update.html
https://www.globenewswire.com//news-release/2024/02/08/2826508/0/en/Molecular-Templates-to-Present-at-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2023/11/13/2779475/0/en/Molecular-Templates-Inc-Reports-Third-Quarter-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com//news-release/2023/11/02/2772842/0/en/Molecular-Templates-Announces-First-Patient-Dosed-in-Phase-1-Trial-Evaluating-MT-8421-a-Novel-Engineered-Toxin-Body-Targeting-CTLA-4-in-Advanced-Solid-Tumors.html
https://www.globenewswire.com//news-release/2023/11/01/2771740/0/en/Molecular-Templates-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/09/28/2751637/0/en/Molecular-Templates-Announces-the-Appointment-of-Dr-Maurizio-Voi-to-the-Role-of-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2023/08/11/2723684/0/en/Molecular-Templates-Announces-1-for-15-Reverse-Stock-Split.html